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Abstract: Viewing tumors as ecosystems offers the opportunity to consider how ecological 
concepts can be translated to novel therapeutic perspectives. The ecological trap concept 
emerged about half a century ago when it was observed that animals can prefer 
environment of low quality for survival over other available of higher quality. The presence 
of such a trap can drive a local population to extinction. The cancer cell trap concept is the 
translation of the ecological trap into glioma therapy. It exploits and diverts the invasive 
potential of glioma cells to guide their migration towards specific locations where a local 
therapy can be delivered efficiently. This illustrates how an ecological concept can change 
therapeutic obstacles into therapeutic tools. 
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Executive Summary 
The ecological trap concept 
 An ecological trap occurs when environmental cues lead animals to migrate and 
settle in poor quality habitat where they experience lower survival or reproductive success. 
 In agriculture, the ecological trap concept has led to the development of attract-and-
kill techniques that combine for example a pheromone with an insecticide for the local 
eradication of pest animals.  
The cancer cell trap concept, a two-step therapy 
The cancer cell trap therapeutic paradigm is the translation of the “attract to kill” 
strategy to cancer therapy. 
Cancer cells are first attracted by non-toxic stimuli towards a therapeutic field where 
lethal radiation doses are then delivered.  
Future perspectives 
The cancer cell trap concept is a conceptual and technological therapeutic challenge 
exploiting and directing cancer cell migration properties. 
Combining the “attract to kill” and “search and destroy” approaches in a unifying 
paradigm will probably be one of the next breakthroughs in cancer therapy 
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Introduction. 
It is now widely accepted that tumors can be considered as ecosystems in which cancer cells, 
host cells and the extracellular matrix interact together [1].
 
Accordingly, cancer cells behave 
like animal species do in an ecosystem. They compete for space and resources, reshape their 
environment, are subjected to predation by the immune system and spread into their tissue 
of origin or migrate to colonize other organs. Considering cancer as an ecological process 
provides the opportunity to consider how concepts of ecology can provide new therapeutic 
perspectives [1,2]. 
Despite decades of research and clinical trials, and more than “60 000 publications” indexed 
in PubMed, glioma remains among the most deadly tumors. The disease usually progresses 
through brain invasion, with glioma cells still detectable several centimeters away from the 
core lesion. The infiltrative nature of glioma cells is a major cause for tumor relapse as it 
limits the long term efficiency of therapeutic approach targeting the tumor mass such as 
brain surgery and radiotherapy (Fig. 1). The containment of the tumor growth in brain that 
can be considered as a single ecosystem, suggests that glioma could be a valuable model for 
investigating how some concepts issued from ecology could be transferred to cancer 
therapy.  
The ecological trap concept. 
The concept of ecological trap emerged more than forty years ago
 
[3] (Fig. 2A). An ecological 
trap occurs when a low-quality habitat is preferred over other available habitats of higher 
quality [4-8]. Ecological traps occur when a novel element in the environment mimics a 
traditional cue for habitat choice, thereby misleading the animals [5]. Importantly, an 
ecological trap can drive a local population to extinction [6].  An example of an ecological 
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trap is provided by the effect of light pollution on sea-turtles hatchlings [4].  When sea-turtle 
hatchlings emerge at night from their sand nests, they move directly toward the brightest 
direction which normally corresponds to the open horizon and therefore to sea (Fig. 2B). 
However, this sea-finding behavior is disrupted when human light sources behind the 
beachfront provide a super-normal stimulus that cue hatchlings to migrate inland where 
they die (Fig. 2B). Importantly, the stimulus is not toxic per se but acts as a misinformation 
cue. Another example is provided with asphalt track and waste oil lakes. Such structures 
have water-imitating polarized light which attract polarization-sensitive water-seekings 
insect with the consequence that eggs laid on such surfaces inevitably perish [7]. Again, the 
ecological trap results from a mismatch between traditionally attractive cues and the actual 
quality of the habitat [5,6]. The principles of ecological trap are of major concern for the 
conservation of animal populations, but they have also been used for the local eradication of 
pest animals. Some examples of behavior modifying compounds used in such attracticide 
approaches include artificial light or pheromone traps to lure pest species to a location 
containing insecticide.
 
Translation of the ecological trap concept to glioma therapy. 
Infiltrative growth is a pathognomic feature of malignant cells and often causes cancer 
relapse, metastasis and consequently death. Regarding glioma, extracranial metastases are 
rare, and in most cases it is the existence of cancer cells in the brain but outside the core 
lesion that makes complete surgical resection impossible and limits other local therapies 
such as radiotherapy. Chemotherapy also failed to eliminate disseminated cancer cells, and 
all attempts to increase drug delivery have not provided major breakthrough. Hence, in 
cancer, tumor relapse and patient death are the consequence of our impossibility to 
eradicate invasive or metastasic cancer cells. Consequently much effort is dedicated to 
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developing anti-invasive therapies [9,10]. A potential limitation of such anti-invasive 
approaches is that the development of invasive cancer cells can be an early event during 
tumor progression [10,11]. For example, in glioblastoma, cancer cells have already moved 
away from the tumor core at the time of diagnosis and even hemispherectomy have not 
ensured eradication of the disease [10]. By analogy with the ecological trap concept and with 
the attracticide technologies developed for pest species, an alternative to anti-invasive 
therapy would be to exploit the invasive potential of glioma cells to guide their migration in 
order to concentrate them towards specific locations where a local therapy could be 
delivered efficiently (Fig. 2C). Rather than inhibiting cancer cell invasion and migration, the 
originality of this attracticide approach exploits and diverts the invasive potential of cancer 
cells themselves for a therapeutic purpose. Attracticide technology also represents an 
alternative to the conventional delivery of chemotherapeutic drugs. Since cancer cells will 
target the site where drug is located, highly effective concentrations can be achieved locally 
while reducing the total amount used compared to conventional therapies. This also 
provides an alternative to conventional radiotherapy by the possibility to focus X- or γ-ray 
microbeams to the sites where attractors or traps are implanted. Moreover, since only 
migrating cells are attracted and contact the trap, the attracticide therapy preserves both 
the tissue environment and normal non-targeted cells. Importantly, the cancer cell trap must 
be viewed as a part of an integrated therapy for the prevention of tumor relapse as a 
complement to therapies that shrink the primary tumor mass.  
The cancer cell trap. 
The cancer cell trap concept requires combining a cancer cell attracting field with a local 
chemotherapeutic and/or radiotherapeutic approach in a single therapeutic device (Fig. 2C). 
After treatment or resection of the solid tumor mass, residual migrating cancer cells are 
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attracted into a site where a cytotoxic therapy is then delivered. This “attract to kill” strategy 
can be considered as a two-step therapy. It first requires attracting cancer cells. Directed cell 
migration plays important roles both in physiological and pathological processes such as host 
defense, wound healing and cancer. In addition biology gradients of concentration guide 
cells and determine cell fate during embryogenesis [12]. In the case of gliomas, invasive 
glioma cells follow myelinated fibers and blood vessels within the perivascular spaces that 
are less densely packed with extracellular matrix [9,13]. Basically cell migration can be 
directed by chemical concentration gradients (chemotaxis), gradients of immobilized surface 
molecules (haptotaxis) or physical stimuli such as electric stimuli (electrotaxis). Several 
neurotransmitters have been shown to have chemoattractive function towards cancer cells 
[14]. Nevertheless, the systematic screening of the chemoattractive potential of 
neurotransmitters towards glioma cells remains to be done. More data are available 
regarding chemoattractive cytokines. For example, neural progenitors are attracted by TNFα 
or IFNγ towards the site of injection where inflammation occurs [15]. Malignant glioma cells 
express several other chemoattractant receptors such as FPR1, CXCR1, CXCR2, CX3CR1 [16].  
Another chemotactic factor for glioma cells is hepatocyte growth factor (HGF) [17]. 
Convection enhanced delivery (CED) can be used to improve the diffusion of such 
chemoattractants in the brain [18,19]. It is noticeable that drug delivery can generate 
concentration gradients which limit the efficiency of anticancer drugs [20].
 
 However, in the 
case of chemoattractive molecules, this limitation in the drug delivery process is exploited as 
it will generate the chemoattractant gradients necessary to direct cell migration. A notable 
point is that many chemoattractive cytokines are also involved in cancer progression since 
they induce for example a motile phenotype. Obviously, the therapeutic use of factors 
known to be involved in tumor growth for cancer therapy seems counter-intuitive. However, 
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this paradox must be overcome as it corresponds to the rationale of an ecological trap i.e. a 
super-normal non-toxic stimulus that cues organisms to migrate into a place they die. In the 
cancer stem cell paradigm, only a subpopulation of cancer cells drive cancer growth and 
tumor relapse. Determining which chemokines are chemoattractive for cancer stem cells is 
therefore critical. In addition to chemical gradients it is recognized that endogenous direct-
current electric fields also provide directional cell migration in a process named electrotaxis 
[21-28]. This guided cell migration is also observed for stem cells [26-28]. A direct current 
electric field of strength 250 mV/mm induces the cathodal migration of neural precursor 
cells but has no effect on their differentiated progeny [27].
 
 Electric fields also direct 
migration of lung, breast and prostate cancer cells and the degree of electrotaxis is more 
significant for invasive cancer cells [24,25,29-31]. Just like pest control in fields depends on 
the optimal position and density of attracticide point sources, the location of tumor traps in 
brain patients will be critical. Since glioma relapse mostly occurs within 2cm around the 
resection cavity [10], implanting the tumor trap in the tumor bed after resection and around 
migratory tracks is a first option. Regarding the delivery of the cytotoxic agent, local delivery 
of drugs such as carmustine with for example wafer implants (Gliadel®) in the postoperative 
tumor bed are currently used. The modest increase in survival for patients [32] is probably 
due to the low diffusion distance of this drug from the wafer into the brain that is limited to 
few millimeters [32,33]. One critical point regarding the low penetration of BCNU is that 
because it is liposoluble it goes into bloodstream through capillary walls before diffusing to 
any appreciable distance [34,35]. On the other hand, high molecular weight molecules such 
as IgG whose diffusivity is nearly 10
6 
smaller than that of BCNU, shows much greater 
penetration depth of nearly 2.2 cm compared to BCNU (0.5 cm) [34]. Therefore the 
generation of gradients could be paradoxically easier with high molecular weight and water 
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soluble proteins than with low liposoluble molecules. Although, drug penetration can be 
enhanced by convection delivery (CED) [18,19], the systemic toxicity required for targeting 
disseminated cancer cells with efficient drug concentrations enlightens the limitation of this 
kind of interstitial therapy approach if it is not combined with a cancer cell attracting field. 
However, because of glioma stem cell chemoresistance, stereotactic radiosurgery with high 
dose delivery is probably the most efficient therapy for targeting trapped cancer cells. 
Recent developments in new radiotherapy protocols have shown that a high radiation dose 
can be applied locally in one shot sparing normal adjacent brain tissue using synchrotron-
generated X-ray beams ('microbeams') or gamma radiation [36-38]. The radiation 
cytotoxicity may be enhanced considerably if radiosensitizing agents are present in the 
cancer cell trap [39].
 
 The cancer cell trap approach should also lead to reevaluate the 
efficiency of stereotactic brachytherapy whose current limited efficiency is probably related to 
cancer cell diffusion in the brain parenchyma [40]. Attracting and concentrating cancer cells in the 
trap location should allow the use of permanent iodine-125 low-activity implants limiting the risk of 
brain necrosis [41]. 
The technological challenge 
A therapy based on the ecological trap strategy will have to overcome several steps before it 
becomes a useful therapeutic tool. The final step for eradication of cancer cells once they 
have been concentrated into the therapeutic field can be managed with the now available 
improved means for irradiation. Indeed, ongoing advances in stereotactic radiosurgery such 
as microbeam radiation therapy are able to deliver with high-precision a radiosurgical 
therapeutic dose to a target volume of 7 mm
3 
while sparing surrounding tissues [37]. 
Probably the most challenging part of the cancer stem cell trap strategy is the generation of 
a cancer stem cell attracting field in vivo. A first step will be to determine the chemotaxis or 
10 
 
electrotaxis parameters capable to guide cancer cell migration in the brain. Experimental 
procedures for tracking the migration of implanted cells in the rodent brain are available. For 
example, modified neural stem cells (NSC) expressing either firefly luciferase or any 
fluorescent protein can be tracked in the rodent brain by bioluminescence imaging or 
multiphoton microscopy [42-45]. This approach has successfully demonstrated the extensive 
capacity of NSC to migrate towards sites of cerebral pathology in the rodent brain [42-45]. 
These in vivo imaging technologies can be used to determine which migratory cues are 
effective to guide implanted cancer cells to specific locations in the brain. Regarding the 
generation of migratory chemotaxis gradients in the brain, a device that can configure such 
gradients in the human brain is not currently available but could be developed. Microfluidic 
devices controlling flow rates, concentrations and release sequence could be combined with 
CED to establish spatial pattern of chemoattractive agents [46,47]. Likewise, combining 
stereotactic injection with CED is another option for creating chemical gradients [48]. The 
creation of chemical gradients in vivo will also benefit of the current progress in the field of 
drug delivery. Surface properties of drug-loaded microparticles can be engineered to interact 
more or less with extracellular matrix [49]. Using a mixture of chemoattractant-loaded 
microparticles with different bioadhesive properties could be a way to generate 
concentration gradients and to combine chemotaxis with haptotaxis. In comparison to 
chemotaxis, electrotaxis has less been studied even if the use of a direct-current electric field 
for guiding cancer cell migration has been successful in vitro [24,25,29-31]. Consequently, 
our knowledge on the mechanisms and on the therapeutic potential of electrotaxis is still in 
its infancy [50]. Currently, research on the therapeutic application of electrotaxis mainly 
focuses on its potential for guiding cells in stem cell therapy or tissue engineering [50-53]. 
Regarding the cell specificity of these attractive cues, we have to consider that every cell in 
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the brain with a high migratory potential could be affected by a therapeutic attracting field. 
In the adult brain, cell migration mainly concerns immune and neural stem cells. Stem cell 
niches in the adult brain are localized in the subgranular zone of the hippocampus and in the 
subventricular zone [54]. Attracting fields should avoid these locations and a set of 
parameters preferentially attracting cancer stem cells should be determined first.  
Once the cancer cell trap concept is validated on animal models, then the efficiency of this 
“attract and kill” strategy can be evaluated on patients after tumor resection. Assessment of 
treatment response will benefit of the combination of advanced magnetic resonance 
imaging (MRI) and position emission tomography (PET) [55-57]. Diffusion Tensor Imaging 
and fluid-attenuated inversion recovery (FLAIR) are two MRI techniques that measure 
changes in the apparent diffusion of water induced by cancer cell invasion or concentration 
[55-57]. In addition to MRI, PET imaging can be used to detect the highly localized 
concentration of cancer cells in the trap and to assess the response to radiosurgery. The 
glucose metabolism (
18
F-2fluoro-2-deoxy-d-glucose (FDG)), amino acid uptake (
11
C- 
methionine (MET) or cell proliferation (
18
F-fluorothymidine (FLT) which all have been shown 
to be increased in glioma cells can be evaluated at the trap site. The amount of 
18
F-FDG 
correlates with the tumor cell density, 
11
C-MET and 
18
F-FLT PET are superior for the 
detection of respectively infiltration zones and cell proliferation zones with high sensitivity 
and specificity [55-57] Finally, overall patient survival will represent the end-point for 
measuring clinical efficacy.  
 
 Perspectives. 
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Cancer therapy since its beginning has been directed by a “search and destroy” 
strategy in which cancer cells are the targets. However the invasive nature of this 
disease, and in the case of glioma its diffusive growth, suggest the interest of a 
complementary “attract and kill” approach. The physician and philosopher of science 
Canguilhem stated “To act, it is necessary at least to localize” [58].  Inspired by the 
concept of ecological trap, the cancer cell trap concentrates and localizes cells into a 
predefined targetable therapeutic field. To achieve this goal the invasive potential of 
cancer cells is exploited and diverted for a therapeutic purpose. In this regard, recent 
evidence suggests that the glioma cell invasive potential can be increased by current 
anti-angiogenic therapies [59]. Combining the tumor trap concept with an anti-
angiogenic therapy could be an option to tackle this therapeutic side effect. Likewise, 
another therapeutic challenge, the existence of drug decreasing concentration gradients 
which limit chemotherapy efficiency [20], is exploited in the cancer cell trap approach to 
generate attractive chemotaxis gradients. Hence, the cancer cell trap concept by turning 
therapeutic obstacles into therapeutic tools can be viewed as an adaptive response to 
cancer cell invasiveness, and tumor relapse. Combining the “attract to kill” and “search 
and destroy” approaches in a unifying therapeutic paradigm will probably be one of the 
next breakthroughs in cancer therapy. 
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Fig 2. Natural, anthropogenically-induced and therapeutic ecological traps. 
An ecological trap arises when a low quality habitat is made more attractive than a high 
quality habitat by a novel element in an environment that mimics a traditional cue for 
habitat choice.  
A: Natural ecological trap: The concept of ecological trap was proposed by Dwernychuk and 
Boag forty years ago as a possible explanation for the observation that ducks and gulls nest 
in close association on islands in inland lakes although gulls attack ducklings [3]. In their 
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interpretation they suggest that terns, which do not attack ducklings, were the first larids to 
occupy these islands, providing protection against other nest predators. The later incursion 
of gulls onto these islands ended the successful relationship between ducks and larids, and 
generated an ecological trap. 
  B: Anthropogenically-induced ecological trap: For hatchling sea turtles emerging 
nocturnally, moonlight acts as a stimulus for sea-finding. Disruption of this sea-finding by 
human photopollution leads to the wandering of turtles to inland where they die [4]. Light or 
pheromone trapping of pest insects is an application of the anthropogenically-induced 
ecological trap principle. 
C: Therapeutic ecological trap:  Invasion of glioma cells throughout brain parenchyma is a 
major cause of therapeutic failure. The cancer cell trap approach exploits the ecological trap 
principles by diverting the cancer cell migratory potential for a therapeutic purpose. In the 
proposed example, the cancer cell trap is implanted in the tumor bed after surgery and 
attracts residual cancer cells. Thereafter, high radiation dose is delivered at the location 
where residual cancer cells have been concentrated.  (purple circles: migrating cancer cells). 
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